{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:59:01Z","timestamp":1792079941525,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01671-5","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:04:32Z","timestamp":1753419872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["UBE2C: a potential therapeutic target and prognostic biomarker for prostate cancer patients"],"prefix":"10.1007","volume":"25","author":[{"given":"Shan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"publisher","unstructured":"Andr\u00e9s-S\u00e1nchez N, Fisher D, Krasinska L (2022) Physiological functions and roles in cancer of the proliferation marker Ki-67. J Cell Sci 135(11). https:\/\/doi.org\/10.1242\/jcs.258932","DOI":"10.1242\/jcs.258932"},{"issue":"5","key":"1671_CR2","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ajpath.2011.01.034","volume":"178","author":"P Bavi","year":"2011","unstructured":"Bavi P, Uddin S, Ahmed M, Jehan Z, Bu R, Abubaker J, et al. (2011) Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via Inhibition of UBE2C in colorectal carcinoma. Am J Pathol 178(5):2109\u20132120. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.034","journal-title":"Am J Pathol"},{"issue":"3","key":"1671_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00432-009-0672-7","volume":"136","author":"S Chen","year":"2010","unstructured":"Chen S, Chen Y, Hu C, Jing H, Cao Y, Liu X (2010) Association of clinicopathological features with UbcH10 expression in colorectal cancer. J Cancer Res Clin Oncol 136(3):419\u2013426. https:\/\/doi.org\/10.1007\/s00432-009-0672-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"1671_CR3","doi-asserted-by":"publisher","unstructured":"Chen J, Xu D, Wang T, Yang Z, Yang Y, He K, Zhao L (2022) HMGB1 promotes the development of castration\u2013resistant prostate cancer by regulating androgen receptor activation. Oncol Rep 48(5). https:\/\/doi.org\/10.3892\/or.2022.8412","DOI":"10.3892\/or.2022.8412"},{"issue":"4","key":"1671_CR5","doi-asserted-by":"publisher","first-page":"e93934","DOI":"10.1371\/journal.pone.0093934","volume":"9","author":"CP Chou","year":"2014","unstructured":"Chou CP, Huang NC, Jhuang SJ, Pan HB, Peng NJ, Cheng JT, et al. (2014) Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PLoS ONE 9(4):e93934. https:\/\/doi.org\/10.1371\/journal.pone.0093934","journal-title":"PLoS ONE"},{"issue":"2","key":"1671_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tcb.2023.05.012","volume":"34","author":"FF Diehl","year":"2024","unstructured":"Diehl FF, Sapp KM, Vander Heiden MG (2024) The bidirectional relationship between metabolism and cell cycle control. Trends Cell Biol 34(2):136\u2013149. https:\/\/doi.org\/10.1016\/j.tcb.2023.05.012","journal-title":"Trends Cell Biol"},{"issue":"5","key":"1671_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2967\/jnumed.119.234914","volume":"61","author":"M Eiber","year":"2020","unstructured":"Eiber M, Kroenke M, Wurzer A, Ulbrich L, Joo\u00df L, Maurer T, et al. (2020) (18)F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate Cancer after radical prostatectomy. J Nucl Med 61(5):696\u2013701. https:\/\/doi.org\/10.2967\/jnumed.119.234914","journal-title":"J Nucl Med"},{"key":"1671_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2407-9-87","volume":"9","author":"T Fujita","year":"2009","unstructured":"Fujita T, Ikeda H, Taira N, Hatoh S, Naito M, Doihara H (2009) Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. BMC Cancer 9:87. https:\/\/doi.org\/10.1186\/1471-2407-9-87","journal-title":"BMC Cancer"},{"issue":"5","key":"1671_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard H, Garc\u00eda-Muse T, Aguilera A (2015) Replication stress and cancer. Nat Rev Cancer 15(5):276\u2013289. https:\/\/doi.org\/10.1038\/nrc3916","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1671_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jmb.2019.09.024","volume":"432","author":"P Garg","year":"2020","unstructured":"Garg P, Ceccarelli DF, Keszei AFA, Kurinov I, Sicheri F, Sidhu SS (2020) Structural and functional analysis of Ubiquitin-based inhibitors that target the backsides of E2 enzymes. J Mol Biol 432(4):952\u2013966. https:\/\/doi.org\/10.1016\/j.jmb.2019.09.024","journal-title":"J Mol Biol"},{"issue":"2","key":"1671_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, De Marzo AM, Nelson PS, Yegnasubramanian S (2021) Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol 18(2):79\u201392. https:\/\/doi.org\/10.1038\/s41585-020-00400-w","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1671_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ijc.22605","volume":"121","author":"K Ieta","year":"2007","unstructured":"Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Inoue H, Kuwano H, Mimori K, Mori M (2007) Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer 121(1):33\u201338. https:\/\/doi.org\/10.1002\/ijc.22605","journal-title":"Int J Cancer"},{"issue":"10437","key":"1671_CR13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/s0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"James ND, Tannock I, N\u2019Dow J, Feng F, Gillessen S, Ali SA, et al. (2024) The lancet commission on prostate cancer: planning for the surge in cases. Lancet 403(10437):1683\u20131722. https:\/\/doi.org\/10.1016\/s0140-6736(24)00651-2","journal-title":"Lancet"},{"key":"1671_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainres.2008.01.037","volume":"1201","author":"L Jiang","year":"2008","unstructured":"Jiang L, Huang CG, Lu YC, Luo C, Hu GH, Liu HM, Chen JX, Han HX (2008) Expression of ubiquitin-conjugating enzyme E2C\/UbcH10 in astrocytic tumors. Brain Res 1201:161\u2013166. https:\/\/doi.org\/10.1016\/j.brainres.2008.01.037","journal-title":"Brain Res"},{"issue":"2","key":"1671_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00432-009-0651-z","volume":"136","author":"L Jiang","year":"2010","unstructured":"Jiang L, Bao Y, Luo C, Hu G, Huang C, Ding X, Sun K, Lu Y (2010) Knockdown of ubiquitin-conjugating enzyme E2C\/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro. J Cancer Res Clin Oncol 136(2):211\u2013217. https:\/\/doi.org\/10.1007\/s00432-009-0651-z","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"1671_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cell.2008.04.012","volume":"133","author":"L Jin","year":"2008","unstructured":"Jin L, Williamson A, Banerjee S, Philipp I, Rape M (2008) Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133(4):653\u2013665. https:\/\/doi.org\/10.1016\/j.cell.2008.04.012","journal-title":"Cell"},{"issue":"34","key":"1671_CR17","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1200\/jco.23.00864","volume":"41","author":"F Kamangar","year":"2023","unstructured":"Kamangar F, Dores GM, Anderson WF (2023) Patterns of Cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce Cancer disparities in different geographic regions of the world. J Clin Oncol 41(34):5209\u20135224. https:\/\/doi.org\/10.1200\/jco.23.00864","journal-title":"J Clin Oncol"},{"issue":"22","key":"1671_CR18","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/onc.2014.238","volume":"34","author":"S Karanika","year":"2015","unstructured":"Karanika S, Karantanos T, Li L, Corn PG, Thompson TC (2015) DNA damage response and prostate cancer: defects, regulation and therapeutic implications. Oncogene 34(22):2815\u20132822. https:\/\/doi.org\/10.1038\/onc.2014.238","journal-title":"Oncogene"},{"key":"1671_CR19","doi-asserted-by":"publisher","unstructured":"Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M (2020) Role of glutathione in cancer: from mechanisms to therapies. Biomolecules 10(10). https:\/\/doi.org\/10.3390\/biom10101429","DOI":"10.3390\/biom10101429"},{"key":"1671_CR20","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1038\/srep06910","volume":"4","author":"SZ Li","year":"2014","unstructured":"Li SZ, Song Y, Zhang HH, Jin BX, Liu Y, Liu WB, Zhang XD, Du RL (2014) UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer. Sci Rep 4:6910. https:\/\/doi.org\/10.1038\/srep06910","journal-title":"Sci Rep"},{"issue":"2","key":"1671_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/1541-7786.Mcr-19-0561","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhao R, Chi S, Zhang W, Xiao C, Zhou X, Zhao Y, Wang H (2020) UBE2C is upregulated by Estrogen and promotes Epithelial-Mesenchymal transition via p53 in endometrial Cancer. Mol Cancer Res 18(2):204\u2013215. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-19-0561","journal-title":"Mol Cancer Res"},{"issue":"8","key":"1671_CR22","doi-asserted-by":"publisher","first-page":"107669","DOI":"10.1016\/j.celrep.2020.107669","volume":"31","author":"MD Nyquist","year":"2020","unstructured":"Nyquist MD, Corella A, Coleman I, De Sarkar N, Kaipainen A, Ha G, et al. (2020) Combined TP53 and RB1 loss promotes prostate Cancer resistance to a spectrum of therapeutics and confers vulnerability to replication stress. Cell Rep 31(8):107669. https:\/\/doi.org\/10.1016\/j.celrep.2020.107669","journal-title":"Cell Rep"},{"issue":"5","key":"1671_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1369\/0022155412439717","volume":"60","author":"I Perrotta","year":"2012","unstructured":"Perrotta I, Bruno L, Maltese L, Russo E, Donato A, Donato G (2012) Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy. J Histochem Cytochem 60(5):359\u2013365. https:\/\/doi.org\/10.1369\/0022155412439717","journal-title":"J Histochem Cytochem"},{"key":"1671_CR24","doi-asserted-by":"publisher","unstructured":"Presta I, Novellino F, Donato A, La Torre D, Palleria C, Russo E, Malara N, Donato G (2020) UbcH10 a major actor in cancerogenesis and a potential tool for diagnosis and therapy. Int J Mol Sci 21(6). https:\/\/doi.org\/10.3390\/ijms21062041","DOI":"10.3390\/ijms21062041"},{"issue":"1","key":"1671_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cell.2005.10.032","volume":"124","author":"M Rape","year":"2006","unstructured":"Rape M, Reddy SK, Kirschner MW (2006) The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124(1):89\u2013103. https:\/\/doi.org\/10.1016\/j.cell.2005.10.032","journal-title":"Cell"},{"issue":"8","key":"1671_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","volume":"6","author":"U Swami","year":"2020","unstructured":"Swami U, McFarland TR, Nussenzveig R, Agarwal N (2020) Advanced prostate cancer: treatment advances and future directions. Trends Cancer 6(8):702\u2013715. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.010","journal-title":"Trends Cancer"},{"issue":"6","key":"1671_CR27","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1073\/pnas.94.6.2362","volume":"94","author":"FM Townsley","year":"1997","unstructured":"Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV (1997) Dominant-negative cyclin-selective ubiquitin carrier protein E2-C\/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci U S A 94(6):2362\u20132367. https:\/\/doi.org\/10.1073\/pnas.94.6.2362","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6220","key":"1671_CR28","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"issue":"4","key":"1671_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3892\/ijo.2017.3880","volume":"50","author":"R Wang","year":"2017","unstructured":"Wang R, Song Y, Liu X, Wang Q, Wang Y, Li L, Kang C, Zhang Q (2017) UBE2C induces EMT through Wnt\/\u03b2\u2013catenin and PI3K\/Akt signaling pathways by regulating phosphorylation levels of Aurora-A. Int J Oncol 50(4):1116\u20131126. https:\/\/doi.org\/10.3892\/ijo.2017.3880","journal-title":"Int J Oncol"},{"issue":"2","key":"1671_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3892\/or.2016.4906","volume":"36","author":"M Yang","year":"2016","unstructured":"Yang M, Qu Y, Shi R, Wu X, Su C, Hu Z, Zhang Z (2016) Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer. Oncol Rep 36(2):779\u2013786. https:\/\/doi.org\/10.3892\/or.2016.4906","journal-title":"Oncol Rep"},{"issue":"6","key":"1671_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.26355\/eurrev_201803_14578","volume":"22","author":"HQ Zhang","year":"2018","unstructured":"Zhang HQ, Zhao G, Ke B, Ma G, Liu GL, Liang H, Liu LR, Hao XS (2018) Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients. Eur Rev Med Pharmacol Sci 22(6):1665\u20131671. https:\/\/doi.org\/10.26355\/eurrev_201803_14578","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1671_CR31","doi-asserted-by":"publisher","first-page":"111868","DOI":"10.1016\/j.biopha.2021.111868","volume":"141","author":"HF Zhang","year":"2021","unstructured":"Zhang HF, Gao X, Wang X, Chen X, Huang Y, Wang L, Xu ZW (2021) The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures. Biomed Pharmacother 141:111868. https:\/\/doi.org\/10.1016\/j.biopha.2021.111868","journal-title":"Biomed Pharmacother"},{"key":"1671_CR33","doi-asserted-by":"publisher","unstructured":"Zhang S, You X, Zheng Y, Shen Y, Xiong X, Sun Y (2023) The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells. J Clin Invest 133(4). https:\/\/doi.org\/10.1172\/jci162434","DOI":"10.1172\/jci162434"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01671-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:08:11Z","timestamp":1769155691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01671-5","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}